ZA200303693B - Anti-adiposis composition based on garlic bulb extracts. - Google Patents
Anti-adiposis composition based on garlic bulb extracts. Download PDFInfo
- Publication number
- ZA200303693B ZA200303693B ZA200303693A ZA200303693A ZA200303693B ZA 200303693 B ZA200303693 B ZA 200303693B ZA 200303693 A ZA200303693 A ZA 200303693A ZA 200303693 A ZA200303693 A ZA 200303693A ZA 200303693 B ZA200303693 B ZA 200303693B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- allium sativum
- adipose
- extract
- active agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 235000004611 garlic Nutrition 0.000 title claims abstract description 89
- 239000000284 extract Substances 0.000 title claims abstract description 60
- 208000008589 Obesity Diseases 0.000 title claims abstract description 14
- 244000245420 ail Species 0.000 title 1
- 240000002234 Allium sativum Species 0.000 claims abstract description 88
- 239000013543 active substance Substances 0.000 claims abstract description 54
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 48
- 238000011282 treatment Methods 0.000 claims abstract description 41
- 208000035484 Cellulite Diseases 0.000 claims abstract description 26
- 206010049752 Peau d'orange Diseases 0.000 claims abstract description 26
- 230000036232 cellulite Effects 0.000 claims abstract description 26
- 239000008601 oleoresin Substances 0.000 claims abstract description 19
- 230000000699 topical effect Effects 0.000 claims abstract description 19
- 230000002500 effect on skin Effects 0.000 claims abstract description 13
- 235000020824 obesity Nutrition 0.000 claims abstract description 13
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 8
- 210000001789 adipocyte Anatomy 0.000 claims description 60
- 238000000034 method Methods 0.000 claims description 52
- 210000000229 preadipocyte Anatomy 0.000 claims description 47
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 33
- 230000008569 process Effects 0.000 claims description 33
- 239000000341 volatile oil Substances 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 22
- 230000004069 differentiation Effects 0.000 claims description 21
- 239000002537 cosmetic Substances 0.000 claims description 17
- 230000001225 therapeutic effect Effects 0.000 claims description 16
- 239000003995 emulsifying agent Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 9
- 206010020880 Hypertrophy Diseases 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 230000005764 inhibitory process Effects 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000000670 limiting effect Effects 0.000 claims description 6
- 230000003449 preventive effect Effects 0.000 claims description 6
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 238000009109 curative therapy Methods 0.000 claims description 5
- 230000002366 lipolytic effect Effects 0.000 claims description 5
- 230000008313 sensitization Effects 0.000 claims description 5
- 206010040880 Skin irritation Diseases 0.000 claims description 4
- 206010070835 Skin sensitisation Diseases 0.000 claims description 4
- 230000036556 skin irritation Effects 0.000 claims description 4
- 231100000475 skin irritation Toxicity 0.000 claims description 4
- 231100000370 skin sensitisation Toxicity 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 8
- 101150110920 FRO1 gene Proteins 0.000 claims 2
- 206010070834 Sensitisation Diseases 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 35
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 14
- 102000016267 Leptin Human genes 0.000 description 12
- 108010092277 Leptin Proteins 0.000 description 12
- 229940039781 leptin Drugs 0.000 description 12
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 230000004130 lipolysis Effects 0.000 description 9
- 210000000577 adipose tissue Anatomy 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 244000223014 Syzygium aromaticum Species 0.000 description 4
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000004132 lipogenesis Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108010055297 Sterol Esterase Proteins 0.000 description 3
- 102000000019 Sterol Esterase Human genes 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000010804 cDNA synthesis Methods 0.000 description 3
- 230000011712 cell development Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000010647 garlic oil Substances 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 101150014691 PPARA gene Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- -1 on the one hand Natural products 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000007115 recruitment Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000001957 sucroglyceride Substances 0.000 description 2
- 235000010964 sucroglyceride Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020648 Hyperkeratoses Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical class [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003919 adipocyte function Effects 0.000 description 1
- 230000002293 adipogenic effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001955 cumulated effect Effects 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000006372 lipid accumulation Effects 0.000 description 1
- 230000003520 lipogenic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000000858 peroxisomal effect Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0013973A FR2815865B1 (fr) | 2000-10-31 | 2000-10-31 | Utilisation d'une composition therapeutique ou cosmetique pour le traitement topique de la cellulite, et composition en comportant l'application |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200303693B true ZA200303693B (en) | 2004-08-13 |
Family
ID=8855935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200303693A ZA200303693B (en) | 2000-10-31 | 2003-05-13 | Anti-adiposis composition based on garlic bulb extracts. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6852343B2 (zh) |
EP (1) | EP1335701B1 (zh) |
JP (1) | JP4124648B2 (zh) |
CN (1) | CN1226996C (zh) |
AT (1) | ATE329575T1 (zh) |
AU (2) | AU1411102A (zh) |
BR (1) | BR0115009A (zh) |
CA (1) | CA2426284A1 (zh) |
CY (1) | CY1105267T1 (zh) |
DE (1) | DE60120744T2 (zh) |
DK (1) | DK1335701T3 (zh) |
ES (1) | ES2266280T3 (zh) |
FR (1) | FR2815865B1 (zh) |
PT (1) | PT1335701E (zh) |
WO (1) | WO2002036093A2 (zh) |
ZA (1) | ZA200303693B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7736661B1 (en) * | 2000-03-07 | 2010-06-15 | Avon Products, Inc | Method of treating skin conditions |
FR2831447B1 (fr) * | 2001-10-26 | 2004-03-12 | Innovaderm | Absolues de bulbes d'allium sativum et utilisations a titre therapeutique ou cosmetique |
US8273024B2 (en) * | 2004-03-16 | 2012-09-25 | Rita Kathleen Chew | Ultrasound transmission gel |
WO2006039285A2 (en) * | 2004-09-30 | 2006-04-13 | The University Of Georgia Research Foundation, Inc. | Compositions and methods for inducing adipose tissue cell death |
JP5049794B2 (ja) * | 2005-06-10 | 2012-10-17 | 株式会社プライマリーセル | 内臓前駆脂肪細胞から内臓脂肪細胞への分化を誘導する方法 |
WO2007089685A2 (en) * | 2006-01-30 | 2007-08-09 | University Of Georgia Research Foundation | Compositions and methods for inducing adipose tissue cell death |
JP2007230981A (ja) * | 2006-03-03 | 2007-09-13 | Hirosaki Univ | ニンニク抽出物又はその分画・画分を有効成分とする心筋リモデリング抑制剤 |
CN108639792B (zh) * | 2018-05-20 | 2023-11-24 | 成都鸿源锦程机器人有限公司 | 一种自动装车机器人的拨臂分料式装车机头 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB842404A (en) * | 1958-06-06 | 1960-07-27 | American Home Prod | Skin treatment composition |
GB1106551A (en) * | 1964-03-18 | 1968-03-20 | Roland Nessim Benhaim | Pharmaceutically-active extracts of the nympheaceae |
FR2628339B1 (fr) * | 1988-03-14 | 1991-04-26 | Rhone Poulenc Chimie | Emulsions aqueuses stables d'huiles essentielles |
FR2660312A1 (fr) * | 1990-03-30 | 1991-10-04 | Ardeval Laboratoires | Compositions a base de plantes fraiches ou seches et leurs applications. |
TW205068B (zh) * | 1991-03-08 | 1993-05-01 | Takeda chemical industry co ltd | |
JPH04338336A (ja) * | 1991-05-15 | 1992-11-25 | Riken Health Kk | 抗肥満剤 |
FR2693371B1 (fr) * | 1992-07-08 | 1994-09-02 | Gisele Melin | Composition pour crème de beauté antirides. |
EP0923937B1 (en) * | 1997-12-08 | 2004-03-10 | Council of Scientific and Industrial Research | A herbal formulation useful as a therapeutic and cosmetic application for the treatment of general skin disorders |
KR100525841B1 (ko) * | 1997-12-27 | 2005-12-21 | 주식회사 엘지생활건강 | 양파 추출물을 함유하는 슬리밍 화장품 조성물 |
DE19858670C2 (de) * | 1998-12-18 | 2001-07-12 | Heinz Kasik | Mittel zur Pflege von Haut, Nägeln und Haaren und zur Förderung des Haarwachstums |
FR2804319B1 (fr) | 2000-01-28 | 2002-10-25 | Clarins Lab | Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp |
-
2000
- 2000-10-31 FR FR0013973A patent/FR2815865B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-26 CN CNB018216129A patent/CN1226996C/zh not_active Expired - Fee Related
- 2001-10-26 ES ES01982561T patent/ES2266280T3/es not_active Expired - Lifetime
- 2001-10-26 AU AU1411102A patent/AU1411102A/xx active Pending
- 2001-10-26 JP JP2002538905A patent/JP4124648B2/ja not_active Expired - Fee Related
- 2001-10-26 AU AU2002214111A patent/AU2002214111B9/en not_active Ceased
- 2001-10-26 US US09/984,037 patent/US6852343B2/en not_active Expired - Fee Related
- 2001-10-26 DE DE60120744T patent/DE60120744T2/de not_active Expired - Fee Related
- 2001-10-26 BR BR0115009-0A patent/BR0115009A/pt not_active IP Right Cessation
- 2001-10-26 AT AT01982561T patent/ATE329575T1/de not_active IP Right Cessation
- 2001-10-26 PT PT01982561T patent/PT1335701E/pt unknown
- 2001-10-26 WO PCT/FR2001/003325 patent/WO2002036093A2/fr active IP Right Grant
- 2001-10-26 CA CA002426284A patent/CA2426284A1/fr not_active Abandoned
- 2001-10-26 EP EP01982561A patent/EP1335701B1/fr not_active Expired - Lifetime
- 2001-10-26 DK DK01982561T patent/DK1335701T3/da active
-
2003
- 2003-05-13 ZA ZA200303693A patent/ZA200303693B/en unknown
-
2006
- 2006-09-13 CY CY20061101304T patent/CY1105267T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR0115009A (pt) | 2003-09-30 |
ATE329575T1 (de) | 2006-07-15 |
AU2002214111B9 (en) | 2006-11-09 |
DK1335701T3 (da) | 2006-10-16 |
DE60120744D1 (de) | 2006-07-27 |
ES2266280T3 (es) | 2007-03-01 |
US6852343B2 (en) | 2005-02-08 |
CA2426284A1 (fr) | 2002-05-10 |
AU1411102A (en) | 2002-05-15 |
FR2815865B1 (fr) | 2003-03-21 |
DE60120744T2 (de) | 2007-06-14 |
WO2002036093A3 (fr) | 2003-01-09 |
EP1335701A2 (fr) | 2003-08-20 |
EP1335701B1 (fr) | 2006-06-14 |
JP2004522704A (ja) | 2004-07-29 |
JP4124648B2 (ja) | 2008-07-23 |
WO2002036093A2 (fr) | 2002-05-10 |
CN1226996C (zh) | 2005-11-16 |
CN1487822A (zh) | 2004-04-07 |
US20020146474A1 (en) | 2002-10-10 |
CY1105267T1 (el) | 2010-03-03 |
AU2002214111B2 (en) | 2006-06-08 |
FR2815865A1 (fr) | 2002-05-03 |
PT1335701E (pt) | 2006-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106580797A (zh) | 一种美白祛斑霜及其制备方法 | |
KR101387308B1 (ko) | 황칠나무 발효산물을 이용한 피부 미백 화장료 조성물 | |
CN112006958A (zh) | 脱毛膏及制备方法 | |
AU2002214111B2 (en) | Anti-adiposis composition based on garlic bulb extracts | |
KR101374277B1 (ko) | 천연물 복합 발효 추출물을 유효성분으로 하는 발모제 조성물 | |
FR3015285A1 (fr) | Formulation pour le traitement des cheveux | |
KR20120003236A (ko) | 닥나무 추출물을 함유하는 여드름 개선용 화장료 조성물 | |
KR100937220B1 (ko) | 여드름 개선용 화장료 조성물 | |
US20080166335A1 (en) | Slimming Cosmetic Composition Comprising a Metalloproteinase as an Active Agent | |
CN107441340B (zh) | 一种消肿止痛止痒滋养皮肤的手足皴裂膏及其制备方法 | |
KR102255264B1 (ko) | 당근의 지상부 추출물을 포함하는 탈모 방지 또는 발모 촉진용 조성물 | |
CA3035305A1 (fr) | Utilisation cosmetique d'un extrait de fruit d'arbutus unedo | |
US7192613B2 (en) | Allium sativum bulb absolutes and therapeutic or cosmetic uses | |
KR20160122052A (ko) | 피뿌리풀 추출물 또는 그의 분획물을 포함하는 상처를 치료하기 위한 조성물 및 개체의 상처를 치료하는 방법 | |
KR102205789B1 (ko) | 천연물 유래 추출물을 포함하는 탈모 방지용 외용제 조성물 및 그 제조방법 | |
KR20240097477A (ko) | 천연 혼합 추출물을 유효성분으로 함유하는 모근 강화 화장료 조성물 | |
CN115463068A (zh) | 一种洋甘菊舒敏霜及其制备方法 | |
KR20010010655A (ko) | 모발 성장 조성물 | |
FR3126870A1 (fr) | Composition pharmaceutique ou cosmétique destinée à améliorer la cellulite et les varices caractérisée en ce qu’elle comprend une association de théanine et des polysaccharides issus du matcha. | |
RU2173982C1 (ru) | Крем-маска для регенерации поврежденных клеток кожи | |
CN107929207A (zh) | 一种保湿美容护手霜 | |
JPH04202117A (ja) | 養毛料 |